Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' JOHNSON HM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Torres, BA; Kominsky, S; Perrin, GQ; Hobeika, AC; Johnson, HM
      Superantigens: The good, the bad, and the ugly

      EXPERIMENTAL BIOLOGY AND MEDICINE
    2. Larkin, J; Subramaniam, PS; Torres, BA; Johnson, HM
      Differential properties of two putative nuclear localization sequences found in the carboxyl-terminus of human IFN-gamma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    3. Subramaniam, PS; Green, MM; Larkin, J; Torres, BA; Johnson, HM
      Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    4. Subramaniam, PS; Torres, BA; Johnson, HM
      So many ligands, so few transcription factors: A new paradigm for signaling through the STAT transcription factors

      CYTOKINE
    5. Kominsky, SL; Torres, BA; Hobeika, AC; Lake, FA; Johnson, HM
      Superantigen enhanced protection against a weak tumor-specific melanoma antigen: Implications for prophylactic vaccination against cancer

      INTERNATIONAL JOURNAL OF CANCER
    6. Larkin, J; Johnson, HM; Subramaniam, PS
      Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    7. Kominsky, SL; Subramaniam, PS; Johnson, HM; Torres, BA
      Inhibitory effects of IFN-gamma and acyclovir on the glioblastoma cell cycle

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    8. Tanabe, T; Kominsky, SL; Subramaniam, PS; Johnson, HM; Torres, BA
      Inhibition of the glioblastoma cell cycle by type i IFNs occurs at both the g1 and s phases and correlates with the upregulation of P21(WAF1/CIP1)

      JOURNAL OF NEURO-ONCOLOGY
    9. Subramaniam, PS; Larkin, J; Mujtaba, MG; Walter, MR; Johnson, HM
      The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site

      JOURNAL OF CELL SCIENCE
    10. Kominsky, SL; Hobeika, AC; Lake, FA; Torres, BA; Johnson, HM
      Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells

      CANCER RESEARCH
    11. Soos, JM; Johnson, HM
      Interferon-tau - Prospects for clinical use in autoimmune disorders

      BIODRUGS
    12. Johnson, TM; Holaday, SK; Sun, YH; Subramaniam, PS; Johnson, HM; Krishna, NR
      Expression, purification, and characterization of interferon-tau produced in Pichia pastoris grown in a minimal medium

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    13. Hobeika, AC; Etienne, W; Torres, BA; Johnson, HM; Subramaniam, PS
      IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition andsuppression of apoptosis

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    14. Mujtaba, MG; Villarete, L; Johnson, HM
      IFN-tau inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    15. Radhakrishnan, R; Walter, LJ; Subramaniam, PS; Johnson, HM; Walter, MR
      Crystal structure of ovine interferon-tau at 2.1 angstrom resolution

      JOURNAL OF MOLECULAR BIOLOGY
    16. Subramaniam, PS; Mujtaba, MG; Paddy, MR; Johnson, HM
      The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Perrin, GQ; Johnson, HM; Subramaniam, PS
      Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle

      BLOOD
    18. Johnson, HM; Seifert, CM
      Modifying mental representations: Comprehending corrections

      CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING
    19. KHAN OA; JIANG H; SUBRAMANIAM PS; JOHNSON HM; DHIBJALBUT SS
      IMMUNOMODULATING FUNCTIONS OF RECOMBINANT OVINE INTERFERON-TAU - POTENTIAL FOR THERAPY IN MULTIPLE-SCLEROSIS AND AUTOIMMUNE DISORDERS

      Multiple sclerosis
    20. TORRES BA; JOHNSON HM
      MODULATION OF DISEASE BY SUPERANTIGENS

      Current opinion in immunology
    21. SUBRAMANIAM PS; CRUZ PE; HOBEIKA AC; JOHNSON HM
      TYPE-I INTERFERON INDUCTION OF THE CDK-INHIBITOR P21(WAF1) IS ACCOMPANIED BY ORDERED G1 ARREST, DIFFERENTIATION AND APOPTOSIS OF THE DAUDI B-CELL LINE

      Oncogene
    22. Kominsky, S; Johnson, HM; Bryan, G; Tanabe, T; Hobeika, AC; Subramaniam, PS; Torres, B
      IFN gamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21(WAF1/CIP1)

      ONCOGENE
    23. MUJTABA MG; STREIT WJ; JOHNSON HM
      IFN-TAU SUPPRESSES BOTH THE AUTOREACTIVE HUMORAL AND CELLULAR IMMUNE-RESPONSES AND INDUCES STABLE REMISSION IN MICE WITH CHRONIC EAE

      The FASEB journal
    24. PERRIN GO; SUBRAMANIAM PS; JOHNSON HM
      IL-2 MEDIATED DOWN-REGULATION OF TUMOR-SUPPRESSOR GENE-PRODUCT P27(KIP1) AND ACTIVATION OF QUIESCENT T-CELLS IS BLOCKED BY IL-10

      The FASEB journal
    25. SUBRAMANIAM PS; MUJTABA MG; SILER KI; PADDY MR; JOHNSON HM
      THE C-TERMINUS OF IFN-GAMMA CONTAINS A FUNCTIONAL NUCLEAR-LOCALIZATION SEQUENCE

      The FASEB journal
    26. GREEN MM; LARKIN J; SUBRAMANIAM PS; SZENTE BE; JOHNSON HM
      HUMAN IFN-GAMMA RECEPTOR CYTOPLASMIC DOMAIN - EXPRESSION AND INTERACTION WITH HUMAN IFN-GAMMA

      The FASEB journal
    27. LARKIN J; ALDRICH HC; PADDY MR; JOHNSON HM; SUBRAMANIAM PS
      THE ROLE OF IFN-GAMMA IN THE NUCLEAR TRANSLOCATION OF THE IFN-GAMMA RECEPTOR AND STAT TRANSCRIPTION FACTORS

      The FASEB journal
    28. KOMINSKY S; TORRES B; BRYAN G; HOBEIKA A; TANABE T; SUBRAMANIAM P; JOHNSON HM
      IFN-GAMMA INHIBITION OF CELL-GROWTH IN GLIOBLASTOMAS IS ACCOMPANIED BY INDUCTION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21

      The FASEB journal
    29. TANABE T; KOMINSKY SL; SUBRAMANIAM PS; JOHNSON HM; TORRES BA
      CELL-CYCLE INHIBITION BY TYPE-I IFNS OCCURS AT BOTH THE G1 AND S-PHASE AND CORRELATES WITH UP-REGULATION OF P21(WAF1)

      The FASEB journal
    30. HOBEIKA AC; ETIENNE W; CRUZ PE; SUBRAMANIAM PS; JOHNSON HM
      IFN-GAMMA INDUCTION OF P21(WAF1) IN PROSTATE-CANCER CELLS - ROLE IN CELL-CYCLE AND CELL PHENOTYPE

      The FASEB journal
    31. JOHNSON HM; SINGH A; YOUNG RHF
      FALL PROTECTION ANALYSIS FOR WORKERS ON RESIDENTIAL ROOFS

      Journal of construction engineering and management
    32. JOHNSON HM; SEIFERT CM
      UPDATING ACCOUNTS FOLLOWING A CORRECTION OF MISINFORMATION

      Journal of experimental psychology. Learning, memory, and cognition
    33. TORRES BA; TANABE T; SUBRAMANIAM PS; YAMAMOTO JK; JOHNSON HM
      MECHANISM OF HIV PATHOGENESIS - ROLE OF SUPERANTIGENS IN DISEASE

      Alcoholism, clinical and experimental research
    34. JOHNSON HM; TORRES BA; GREEN MM; SZENTE BE; SILER KI; LARKIN J; SUBRAMANIAM PS
      HYPOTHESIS - LIGAND RECEPTOR-ASSISTED NUCLEAR TRANSLOCATION OF STATS/

      Proceedings of the Society for Experimental Biology and Medicine
    35. HOBEIKA AC; ETIENNE W; CRUZ PE; SUBRAMANIAM PS; JOHNSON HM
      IFN-GAMMA INDUCTION OF P21(WAF1) IN PROSTATE-CANCER CELLS - ROLE IN CELL-CYCLE, ALTERATION OF PHENOTYPE AND INVASIVE POTENTIAL

      International journal of cancer
    36. MUJTABA MG; STREIT WJ; JOHNSON HM
      IFN-TAU SUPPRESSES BOTH THE AUTOREACTIVE HUMORAL AND CELLULAR IMMUNE-RESPONSES AND INDUCES STABLE REMISSION IN MICE WITH CHRONIC EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Cellular immunology (Print)
    37. GREEN MM; LARKIN J; SUBRAMANIAM PS; SZENTE BE; JOHNSON HM
      HUMAN IFN-GAMMA RECEPTOR CYTOPLASMIC DOMAIN - EXPRESSION AND INTERACTION WITH HUIFN-GAMMA (VOL 243, PG 170, 1998)

      Biochemical and biophysical research communications
    38. JOHNSON HM; TORRES BA; GREEN MM; SZENTE BE; SILER KI; LARKIN J; SUBRAMANIAM PS
      CYTOKINE-RECEPTOR COMPLEXES AS CHAPERONES FOR NUCLEAR TRANSLOCATION OF SIGNAL TRANSDUCERS

      Biochemical and biophysical research communications
    39. GREEN MM; LARKIN J; SUBRAMANIAM PS; SZENTE BE; JOHNSON HM
      HUMAN IFN-GAMMA RECEPTOR CYTOPLASMIC DOMAIN - EXPRESSION AND INTERACTION WITH HUIFN-GAMMA

      Biochemical and biophysical research communications
    40. SUBRAMANIAM PS; JOHNSON HM
      A ROLE FOR THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 IN THE G(1) CELL-CYCLE ARREST MEDIATED BY THE TYPE-I INTERFERONS (VOL 17, PG 14, 1997)

      Journal of interferon & cytokine research
    41. SUBRAMANIAM PS; JOHNSON HM
      A ROLE FOR THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 IN THE G(1) CELL-CYCLE ARREST MEDIATED BY THE TYPE-I INTERFERONS

      Journal of interferon & cytokine research
    42. HOBEIKA AC; SUBRAMANIAM PS; JOHNSON HM
      IFN-ALPHA INDUCES THE EXPRESSION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 IN HUMAN PROSTATE-CANCER CELLS

      Oncogene
    43. CRUZ PE; SUBRAMANIAM PS; JOHNSON HM
      MECHANISM FOR DIFFERENTIAL INDUCTION OF APOPTOSIS BY TYPE-I INTERFERONS

      The FASEB journal
    44. HOBEIKA AC; SUBRAMANIAM PS; JOHNSON HM
      INTERFERON INDUCTION OF THE TUMOR-SUPPRESSOR P21 INHIBITS CELL-CYCLE OF TUMOR-CELLS

      The FASEB journal
    45. SUBRAMANIAM PS; CRUZ PE; HOBEIKA AC; JOHNSON HM
      TYPE-I IFN INDUCTION OF THE CDK-INHIBITOR P21(WAF1) IS ACCOMPANIED BYORDERED G1 ARREST, DIFFERENTIATION AND APOPTOSIS IN THE DAUDI B-CELL LINE

      The FASEB journal
    46. JOHNSON HM
      LEGISLATING DEATH

      ABA journal
    47. JOHNSON HM
      THE KOTO - MUSICAL-INSTRUMENT, MATERIAL CULTURE, AND MEANING (JAPAN, TRADITIONAL-MUSIC)

      Journal of the American Musical Instrument Society
    48. SOOS JM; SCHIFFENBAUER J; TORRES BA; JOHNSON HM
      SUPERANTIGENS AS VIRULENCE FACTORS IN AUTOIMMUNITY AND IMMUNODEFICIENCY DISEASES

      Medical hypotheses
    49. MUJTABA MG; SOOS JM; JOHNSON HM
      CD4-T-SUPPRESSOR CELLS MEDIATE INTERFERON-TAU PROTECTION AGAINST EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Journal of neuroimmunology
    50. SOOS JM; MUJTABA MG; SUBRAMANIAM PS; STREIT WJ; JOHNSON HM
      ORAL-FEEDING OF INTERFERON-TAU CAN PREVENT THE ACUTE AND CHRONIC RELAPSING FORMS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Journal of neuroimmunology
    51. KHAN OA; JIANG H; JOHNSON HM; DHIBJALBUT S
      EFFECT OF RECOMBINANT OVINE INTERFERON-TAU ON HUMAN T-CELL RESPONSES AND HLA-EXPRESSION - POTENTIAL FOR THERAPY IN MULTIPLE-SCLEROSIS

      Neurology
    52. PONTZER CH; YAMAMOTO JK; BAZER FW; OTT TL; JOHNSON HM
      POTENT ANTI-FELINE IMMUNODEFICIENCY VIRUS AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS EFFECT OF IFN-TAU

      The Journal of immunology
    53. JABLONSKY MJ; SUBRAMANIAN PS; JOHNSON HM; RUSSELL JK; KRISHNA NR
      THE SOLUTION STRUCTURE OF A CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEXSUPERANTIGEN BINDING DOMAIN

      Biochemical and biophysical research communications
    54. TANABE T; TORRES BA; SUBRAMANIAM PS; JOHNSON HM
      V-BETA ACTIVATION BY HIV NEF PROTEIN - DETECTION BY A SIMPLE AMPLIFICATION PROCEDURE

      Biochemical and biophysical research communications
    55. SZENTE BE; WEINER IJ; JABLONSKY MJ; KRISHNA NR; TORRES BA; JOHNSON HM
      STRUCTURAL REQUIREMENTS FOR AGONIST ACTIVITY OF A MURINE INTERFERON-GAMMA PEPTIDE

      Journal of interferon & cytokine research
    56. MUJTABA MG; SOOS JM; JOHNSON HM
      CD4 T-CELLS MEDIATE INTERFERON PROTECTION AGAINST EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      The FASEB journal
    57. TANABE T; TORRES BA; SUBRAMANIAM P; JOHNSON HM
      HIV NEF - A SIMPLE METHOD FOR MAPPING THE V-BETA PROFILE OF A WEAK SUPERANTIGEN

      The FASEB journal
    58. TORRES BA; TANABE T; YAMAMOTO JK; JOHNSON HM
      HIV ENCODES FOR ITS OWN CD4 T-CELL SUPERANTIGEN MITOGEN

      The FASEB journal
    59. SUBRAMANIAM PS; JOHNSON HM
      INTERFERON-TAU (IFN-TAU) AND INTERFERON-ALPHA (IFN-ALPHA) REGULATE DIFFERENT EVENTS OF THE CELL-CYCLE

      The FASEB journal
    60. HOBEIKA A; SUBRAMANIAM PS; JOHNSON HM
      BIOCHEMICAL EFFECTS OF TYPE-I INTERFERONS ON PROSTATE-CANCER CELL-CYCLE

      The FASEB journal
    61. TORRES BA; TANABE T; JOHNSON HM
      REPLICATION OF HIV-1 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS ACTIVATED BY EXOGENOUS NEF

      AIDS
    62. JOHNSON HM
      A KOTO BY ANY OTHER NAME - EXPLORING JAPANESE SYSTEMS OF MUSICAL-INSTRUMENT CLASSIFICATION

      Asian music
    63. JOHNSON HM; TORRES BA; SOOS JM
      SUPERANTIGENS - STRUCTURE AND RELEVANCE TO HUMAN-DISEASE

      Proceedings of the Society for Experimental Biology and Medicine
    64. JOHNSON HM
      RESOLUTION OF MASS PRODUCT LIABILITY LITIGATION WITHIN THE FEDERAL-RULES - A CASE FOR THE INCREASED USE OF RULE 23(B)(3) CLASS-ACTIONS

      Fordham law review
    65. TORRES BA; TANABE T; YAMAMOTO JK; JOHNSON HM
      HIV ENCODES FOR ITS OWN CD4 T-CELL SUPERANTIGEN MITOGEN

      Biochemical and biophysical research communications
    66. TORRES BA; TANABE T; JOHNSON HM
      CHARACTERIZATION OF NEF-INDUCED CD4 T-CELL PROLIFERATION

      Biochemical and biophysical research communications
    67. HOBEIKA AC; JOHNSON HM
      A NEUTRALIZING EPITOPE OF THE SUPERANTIGEN SEA HAS AGONIST ACTIVITY ON T-CELLS

      Biochemical and biophysical research communications
    68. SOOS JM; JOHNSON HM
      TYPE-I INTERFERON INHIBITION OF SUPERANTIGEN STIMULATION - IMPLICATIONS FOR TREATMENT OF SUPERANTIGEN-ASSOCIATED DISEASE

      Journal of interferon & cytokine research
    69. SOOS JM; SUBRAMANIAM PS; SCHIFFENBAUER J; JOHNSON HM
      THE NOVEL TYPE-I INTERFERON-TAU PREVENTS DEVELOPMENT AND SUPERANTIGENREACTIVATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN MICE WITHOUT ASSOCIATED TOXICITY

      The FASEB journal
    70. YAMAMOTO JK; PU RY; ANDERSON J; GENGOZIAN N; CHARI SC; JOHNSON HM; PECK AB; SOOS JM
      IMMUNE STATUS OF ANIMALS VACCINATED AGAINST LENTIVIRUS - FELINE IMMUNODEFICIENCY VIRUS MODEL FOR VACCINE DEVELOPMENT

      The FASEB journal
    71. HOBEIKA AC; JOHNSON HM
      EVIDENCE THAT RESIDUES-121-149 OF THE STAPHYLOCOCCAL SUPERANTIGEN SEAARE CRITICAL FOR SUPERANTIGEN ACTIVITY

      The FASEB journal
    72. SZENTE BE; SUBRAMANIAM PS; JOHNSON HM
      SPECIFIC ASSOCIATION OF THE JANUS KINASE JAK2 WITH THE INTERFERON-GAMMA RECEPTOR-ALPHA CHAIN AND THE EFFECT OF INTERFERON-GAMMA (IFN-GAMMA)AND IFN-GAMMA PEPTIDES

      The FASEB journal
    73. TORRES BA; TANABE T; JOHNSON HM
      T-CELL ACTIVATION-INDUCED BY HIV-1 NEF PROTEIN

      The FASEB journal
    74. SUBRAMANIAM PS; KHAN SA; PONTZER CH; JOHNSON HM
      DIFFERENTIAL RECOGNITION OF THE TYPE-I INTERFERON RECEPTOR BY INTERFERON-TAU AND INTERFERON-ALPHA IS RESPONSIBLE FOR THEIR DISPARATE CYTOTOXICITIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    75. SOOS JM; HOBEIKA AC; BUTFILOSKI EJ; SCHIFFENBAUER J; JOHNSON HM
      ACCELERATED INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN PL J MICE BY A NON-V(BETA)8-SPECIFIC SUPERANTIGEN/

      Proceedings of the National Academy of Sciences of the United Statesof America
    76. SOOS JM; SUBRAMANIAM PS; HOBEIKA AC; SCHIFFENBAUER J; JOHNSON HM
      THE IFN PREGNANCY RECOGNITION HORMONE IFN-TAU BLOCKS BOTH DEVELOPMENTAND SUPERANTIGEN REACTIVATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITHOUT ASSOCIATED TOXICITY

      The Journal of immunology
    77. SZENTE BE; SUBRAMANIAM PS; JOHNSON HM
      IDENTIFICATION OF IFN-GAMMA RECEPTOR-BINDING SITES FOR JAK2 AND ENHANCEMENT OF BINDING BY IFN-GAMMA AND ITS C-TERMINAL PEPTIDE IFN-GAMMA(95-133)

      The Journal of immunology
    78. SOOS JM; JOHNSON HM
      TYPE-I INTERFERON INHIBITION OF SUPERANTIGEN ACTIVITY - IMPLICATIONS FOR TREATMENT OF AUTOIMMUNITY

      The FASEB journal
    79. SZENTE BE; JOHNSON HM
      IDENTIFICATION OF AN IFN-GAMMA BINDING-SITE ON THE INTRACELLULAR DOMAIN OF THE MURINE IFN-GAMMA RECEPTOR

      The FASEB journal
    80. SEIFERT CM; HAMMOND KJ; JOHNSON HM; CONVERSE TM; MCDOUGAL TF; VANDERSTOEP SW
      CASE-BASED LEARNING - PREDICTIVE FEATURES IN INDEXING

      Machine learning
    81. LINDSAY JA; JOHNSON HM; WALLACE FM; SOOS JM
      CAN SUPERANTIGENS TRIGGER SUDDEN INFANT DEATH

      Medical hypotheses
    82. JOHNSON HM; SEIFERT CM
      SOURCES OF THE CONTINUED INFLUENCE EFFECT - WHEN MISINFORMATION IN MEMORY AFFECTS LATER INFERENCES

      Journal of experimental psychology. Learning, memory, and cognition
    83. JARPE MA; JOHNSON HM; BAZER FW; OTT TL; CURTO EV; KRISHNA NR; PONTZER CH
      PREDICTED STRUCTURAL MOTIF OF IFN-TAU

      Protein engineering
    84. PONTZER CH; OTT TL; BAZER FW; JOHNSON HM
      STRUCTURE FUNCTION STUDIES WITH INTERFERON-TAU - EVIDENCE FOR MULTIPLE ACTIVE-SITES/

      Journal of interferon research
    85. JOHNSON HM; BAZER FW; SZENTE BE; JARPE MA
      HOW INTERFERONS FIGHT DISEASE

      Scientific American
    86. JOHNSON HM
      PROCESSES OF SUCCESSFUL INTENTIONAL FORGETTING

      Psychological bulletin
    87. SZENTE BE; SOOS JM; JOHNSON HM
      THE C-TERMINUS OF IFN-GAMMA IS SUFFICIENT FOR INTRACELLULAR FUNCTION

      Biochemical and biophysical research communications
    88. SOOS JM; JOHNSON HM
      MULTIPLE BINDING-SITES ON THE SUPERANTIGEN, STAPHYLOCOCCAL-ENTEROTOXIN-B, IMPARTS VERSATILITY IN BINDING TO MHC CLASS-II MOLECULES

      Biochemical and biophysical research communications
    89. SZENTE BE; JOHNSON HM
      BINDING OF IFN-GAMMA AND ITS C-TERMINAL PEPTIDE TO A CYTOPLASMIC DOMAIN OF ITS RECEPTOR THAT IS ESSENTIAL FOR FUNCTION

      Biochemical and biophysical research communications
    90. TORRES BA; JOHNSON HM
      IDENTIFICATION OF AN HIV-1 NEF PEPTIDE THAT BINDS TO HLA CLASS-II ANTIGENS

      Biochemical and biophysical research communications
    91. JARPE MA; JOHNSON HM
      STABLE CONFORMATION OF AN INTERFERON-GAMMA RECEPTOR-BINDING PEPTIDE IN AQUEOUS-SOLUTION IS REQUIRED FOR INTERFERON-GAMMA ANTAGONIST ACTIVITY

      Journal of interferon research
    92. OTT TL; VANHEEKE G; HOSTETLER CE; SCHALUE TK; OLMSTED JJ; JOHNSON HM; BAZER FW
      INTRAUTERINE INJECTION OF RECOMBINANT OVINE INTERFERON-TAU EXTENDS THE INTERESTROUS INTERVAL IN SHEEP

      Theriogenology
    93. JOHNSON HM
      RACISM IN SCIENCE - REPLIES

      Scientific American
    94. TORRES BA; GRIGGS ND; JOHNSON HM
      BACTERIAL AND RETROVIRAL SUPERANTIGENS SHARE A COMMON BINDING REGION ON CLASS-II MHC ANTIGENS

      Nature
    95. SCHIFFENBAUER J; JOHNSON HM; BUTFILOSKI EJ; WEGRZYN L; SOOS JM
      STAPHYLOCOCCAL ENTEROTOXINS CAN REACTIVATE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    96. VANVOLKENBURG MA; GRIGGS ND; JARPE MA; PACE JL; RUSSELL SW; JOHNSON HM
      BINDING-SITE ON THE MURINE IFN-GAMMA RECEPTOR FOR IFN-GAMMA HAS BEEN IDENTIFIED USING THE SYNTHETIC PEPTIDE APPROACH

      The Journal of immunology
    97. SOOS JM; SCHIFFENBAUER J; WEGRZYN L; JOHNSON HM
      EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS CAN BE BOTH PREVENTED AND RE-ACTIVATED BY A BACTERIAL SUPERANTIGEN

      The Journal of immunology
    98. VANVOLKENBURG MA; GRIGGS ND; RUSSELL SW; PACE JL; JOHNSON HM
      A PORTION OF THE INTERIOR DOMAIN OF THE MURINE IFN-GAMMA RECEPTOR IS THE BINDING-SITE FOR IFN-GAMMA

      The Journal of immunology
    99. TORRES BA; GRIGGS ND; JOHNSON HM
      BACTERIAL AND RETROVIRAL SUPERANTIGENS SHARE A COMMON REGION ON CLASS-II MHC ANTIGENS

      The Journal of immunology
    100. SAKAI TT; JABLONSKY MJ; DEMUTH PA; KRISHNA NR; JARPE MA; JOHNSON HM
      PROTON NMR SEQUENCE-SPECIFIC ASSIGNMENTS AND SECONDARY STRUCTURE OF ARECEPTOR-BINDING DOMAIN OF MOUSE GAMMA-INTERFERON

      Biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 08:24:37